The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study - Quiz - MDSpire

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study

  • By

  • Aspasia Manta

  • Afroditi Roumpou

  • Maria Gerogianni

  • Roubini Zakopoulou

  • Kimon Tzannis

  • Areti Mamali

  • Vasiliki Malamatini

  • Konstantina Kakogianni

  • Aristotelis Bamias

  • Melpomeni Peppa

  • June 30, 2026

  • 0 min

Share

Original Source(s)

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study

  • by Aspasia Manta, Afroditi Roumpou, Maria Gerogianni, Roubini Zakopoulou, Kimon Tzannis, Areti Mamali, Vasiliki Malamatini, Konstantina Kakogianni, Aristotelis Bamias, Melpomeni Peppa

  • June 30, 2026

Related Content

Alectinib combined with 5-aminolevulinic acid-based photodynamic therapy promotes apoptosis in endometrial cancer cells by targeting ferrochelatase

This Week's CGT News: World's First Solid Tumor CAR T Approved in China 

  • June 30, 2026

  • 6 min
Artificial intelligence for triple-negative breast cancer from imaging to multi-omics